Switching to second‐generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib‐treated patients with chronic myeloid leukemia with more than 10% of BCR‐ABL/ABL ratio at 3 months

Publisher： John Wiley & Sons Inc

E-ISSN： 2045-7634|4|7|995-1002

ISSN： 2045-7634

Source： Cancer Medicine, Vol.4, Iss.7, 2015-07, pp. : 995-1002

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple copies of BCR-ABL fusion gene on two isodicentric Philadelphia chromosomes in an imatinib mesylateresistant chronic myeloid leukemia patient

By          

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1579-1582

Spandidos Publications

Access to resources Recommend Favorite

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate

By Hardling Mats   Wei Yuan   Palmqvist Lars   Swolin Birgitta   Stockelberg Dick   Gustavsson Bengt   Ekeland-Sjöberg Kerstin   Wadenvik Hans   Ricksten Anne  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 349-358

Humana Press, Inc

Access to resources Recommend Favorite

CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation

By                    

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 253-261

Spandidos Publications

Access to resources Recommend Favorite

Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 347-355

Bentham Science Publishers

Access to resources Recommend Favorite

Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients

By                    

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 181-187

Spandidos Publications

Access to resources Recommend Favorite